News Link •
Global
Oral pill cuts bad cholesterol by 60% in phase 2 clinical trial
• arcleinThe new trial investigated the efficacy of MK-0616 as an oral PCSK9 inhibitor. Over 380 participants enrolled, who all had elevated levels of LDL cholesterol and a history of heart disease or risk factors for it. They were randomly assigned to one of
